Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

Leslie Cho, MD, FACC, FESC, FSCAI, and Seth S. Martin, MD, MHS, FACC, FAHA, FASPC, open a discussion regarding therapies for statin-intolerant patients with ASCVD and provide an overview of the CLEAR Outcomes clinical trial. 

Bempedoic acid provides an effective treatment alternative for patients with statin intolerance due to differences in mechanisms of action.

Key opinion leaders discuss parameters and limitations of the CLEAR Outcomes clinical trial.

Medical experts highlight key findings from the CLEAR Outcomes trial.

Drs Cho and Martin examine the side effect profile associated with bempedoic acid.

In their final thoughts, the experts illustrate the overall effect of bempedoic acid for statin-intolerant patients with atherosclerotic cardiovascular disease.